Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor

Authors

Keywords

Immune checkpoint inhibitor, Programed death 1 receptor (PD-1), PD-1 ligand (PD-L1), Interstitial nephritis, Pembrolizumab, Nivolumab

Journal

Volume 5, Issue 1, Pages -

Publisher

Springer Nature

Online

2017-01-10

DOI

10.1186/s40425-016-0205-2

References

View 5 related references

Contact the author

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started